Lisa Lindquist, MD is the Chair of Psychiatry at Providence Alaska Medical Center. She also serves as Medical Director of the Consult Liaison Psychiatry Service and the Electroconvulsive Therapy Service. While at Providence, Lisa has been involved in the development of the Opioid Use Disorder Clinical Pathway, which has been adopted by the Providence St. Joseph Health System. As a member of the Pain Management Council and the Substance Misuse and Prevention Council, she has been involved in the development of clinical practice guidelines for addiction, as well as nursing and physician education. Lisa is currently involved in the expansion of interventional psychiatry at Providence Alaska Medical Center, to include ketamine-assisted psychotherapy, electroconvulsive therapy, and brexanolone (an infusion for the treatment of post-partum depression).
Prior to joining Providence, Lisa served as Chief Resident for the General Psychiatry Residency at University of North Carolina Hospitals, where she completed her psychiatry residency and received additional training in psychosomatic medicine, perinatal psychiatry, and addiction psychiatry. While at UNC, she received the Rita Bernstein Weisler Award for Residency Research for her research on military traumatic brain injury.
Lisa was born and raised in Alaska. She attended Auburn University (War Eagle!), where she received a bachelor’s degree in Biomedical Sciences. She received her Doctorate of Medicine from the University of Washington as a member of Alaska WWAMI. Lisa is a Diplomate of the American Boad of Psychiatry and Neurology. Lisa is a member of the American Academy of Consultation-Liaison Psychiatry, the American Psychiatric Association, the International Society for ECT and Neuromodulation, and Marce of North America (formerly the Perinatal Mental Health Society). She now lives in Eagle River with her husband and two young sons.